We are developing a novel MDMA patch to treat a variety of diseases
The microneedle patch delivery technology was invented and developed by the members of the Khademhosseini Lab at UCLA. The MDMA patch has biocompatible and biodegradable properties, can efficiently penetrate the stratum corneum layer (outer layer of the skin), enable flexible drug load capacity and combinations, and control-release delivery. The microneedle patch are minimally invasive, painless, and may overcome the potential drawbacks of oral administration, subcutaneous injections and other transdermal delivery systems.
We Are Changing How Psychedelics Are Delivered with a Microneedle Patch
Patient freedom - pain-free, home use, convenient and improves compliance
Flexible dosing - drug combinations, continuous delivery and desired release rates
Improve efficacy - maintains constant plasma levels for over 24 hours
Next generation delivery - improvement over intravenous, oral, injection, pumps, topical, nose